Oncology
of interest
are looking at
saved
next event
Podcast series: Molecular biomarker testing for prostate cancer
Listen to experts discuss the latest on molecular biomarker testing for prostate cancer, in this podcast series.
Lead from the frontline: Optimizing first-line treatment selection in Ph+ ALL
Join experts Elias Jabbour, Hagop Kantarjian and Nicholas Short from the 2023 ASCO annual meeting as they discuss Ph+ ALL treatment options and gain 1 CME credit.
Symposium on refractory multiple myeloma, COMy 2023
Watch our expert panel discussion on the management of relapsed and refractory multiple myeloma (RRMM) in older and frail adults.
How can poor-quality clinical trials impact clinical decision-making?
Explore why a cautious approach is warranted when interpreting trial results.
In this section
Bladder Cancer
Containing relevant Learning Zones, guidelines, trials and news.
Breast Cancer
Containing relevant Learning Zones, guidelines, trials and news.
Non-small cell lung cancer
Containing relevant Learning Zones, guidelines, trials and news.
Ovarian cancer
Containing relevant Learning Zones, guidelines, trials and news.
Prostate Cancer
Containing relevant Learning Zones, guidelines, trials and news.
Thyroid cancer
Containing relevant Learning Zones, guidelines, trials and news.
Related news and insights
Related Drugs
Related Guidelines
Related Events
What are the most common cancers in women?
The most common cancers in females globally are breast cancer (24.2%), colorectum cancer (9.5%), and lung cancer (8.4%)1. These are also the three most common causes of cancer-related deaths in women, with breast cancer being the most common1. The most common type of breast cancer is invasive ductal carcinoma, whilst the molecular subtypes of breast cancer that are more relevant for treatment-decision making include luminal A, luminal B, triple negative, HER2-enriched, and normal-like breast cancer2. Whilst breast cancer is much more common in women, just under 1% of all breast cancer cases are male breast cancers3. In gynaecological oncology, female-only cancers include ovarian cancer, cervical cancer, womb cancer, vulval cancer, and vaginal cancer.
What are the most common cancers in men?
The most common cancers in men globally include lung cancer (14.5%), prostate cancer (13.5%) and colorectum cancers (10.9%)1. Whilst lung cancer is also the most common cause of cancer-related deaths in men, prostate cancer and colorectum cancer follow in 6th and 5th position, respectively, following liver cancer and stomach cancer1. Male-only cancers include prostate cancer, testicular cancer, and penile cancer.
How is cancer treated?
Cancer treatments used within clinical oncology vary according to type and subtype of cancer, cancer stage and level of metastases, as well as the molecular features of the cancer. Cancer treatment modalities include surgery, radiation therapy, chemotherapy, radiopharmaceuticals, immunotherapy, hormone therapy, targeted therapy and stem cell transplant therapy. Tumour biomarker analysis using molecular techniques that include cancer genetic testing are increasingly important for the application of current and emerging targeted cancer therapies, an approach known as individualised cancer treatment, or precision medicine4.
References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- Breastcancer.org. Molecular subtypes of breast cancer. https://www.breastcancer.org/symptoms/types/molecular-subtypes. Accessed 14 March 2021.
- Breastcancer.org. Male breast cancer. https://www.breastcancer.org/symptoms/types/male_bc#:~:text=Breast%20cancer%20in%20men%20is,is%20about%201%20in%20833. Accessed 14 March 2021.
- Le Tourneau C, Borcoman E, Kamal M. Molecular profiling in precision medicine oncology. Nat Med. 2019;25(5):711–712.